BKN301 is a series a startup based in Indonesia. 1 investor tracked.
BKN301 is a company headquartered in Indonesia. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
BKN301 is a clinical-stage biotech company focused on the discovery and development of innovative therapies targeting gastrointestinal (GI) diseases with high unmet medical need.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.